Dr Ariel Beresniak explains in this article that the lockdown strategy has never been considered as a public health intervention against respiratory virus pandemics, and has many uncontrolable health and economic adverse consequences.
Dr. Ariel Beresniak, CEO and founder of Data Mining International and Gérard Duru, Senior Research Partner of Data Mining International,
have co-authored with Elsevier, the publication “Economie de la Santé”.
The publication “Economie de la Santé” presents the stakes within health economics, and the methods and tools for economic health evaluations, for estimating the value of innovations in health and for finding the balance between solidarity and freedom.
The publication is structured as follows:
Dr. Ariel Beresniak, CEO and founder of Data Mining International reviews in this article in Causeur magazine, the highly controversial situation where the internationally reputed scientific journal The Lancet took its distance from the study it had previously published on the dangers of chloroquine.
Link to the article
The Lancet – Les Tromperies de la Renommée
Dr. Ariel Beresniak presents an analysis behind economic decisions being made amidst Covid-19, in this article for Causeur Magazine in May 2020.
Link to the article
Causeur Magazine – Le Coût de la Vie
During unsettling Covid-19 times of emergency, Dr. Ariel Beresniak puts science back to its rightful place as a benchmark for decision-making, in this article published in Causeur magazine on 4th May 2020.
Amid Covid-19 uncertainty, Dr. Ariel Beresniak was interviewed in this article by Corse Matin on Representative Seroprevalence Study.
Link to the article
Corse Matin – En Corse, quelles stratégies pour le déconfinement?
Test-and-treat strategy using Urea Breath Tests is proven to be cost-effective in managing symptoms and consequences from Helicobacter pylori infection, thus contributing to preventing peptic ulcer and gastric cancer.
For more information regarding this subject please refer to our Press Release.
Almost 60% of the world population is infected with the Helicobacter pylori bacteria: a new study establishes that a test-and-treat strategy using Urea Breath Tests is cost-effective in managing symptoms and consequences from this infection, thus contributing to prevent peptic ulcer and gastric cancer.
Helicobacter pylori infection is a major public health issue affecting 60% of the world’s population with 90% of Peptic Ulcer attributed to and 80% of Gastric Cancers associated with Hp infection.
With the support of an international expert panel composed of […]
Dr Ariel Beresniak took part in the Ethics Prize Seminar in Stockholm in October 2016, where he discussed once again how inadequate, inaccurate and unethical the QALY approach is when used for making a decision about new medicines’ access to patients in need.
This seminar was organised by the Swedish Council of Medical Ethics.
The full seminar broadcast can be viewed here. Dr Ariel Beresniak’s presentation starts at 1:50:13.
More information on the QALYs and DMI’s role in the ECHOUTCOME project: www.echoutcome.eu.
The European research project Electronic Health Records for Clinical Research (EHR4CR) was co-funded by the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) under the Innovative Medicines Initiative. A new budgetary impact assessment published in the Journal of Health & Medical Informatics reveals that compared to current practices, the EHR4CR platform appears cost-saving for pharmaceutical industry, the primary sponsor of clinical trials.
The full article is available here.
More information on the EHR4CR project: www.ehr4cr.eu.